Early research (Phase 1)Looking for participantsNCT05500807
What this trial is testing
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Who this might be right for
Von Willebrand Disease, Type 3Concomitant VWD and Hemophilia
Bleeding and Clotting Disorders Institute Peoria, Illinois 40